160 related articles for article (PubMed ID: 9163605)
21. Isolated 13q14 abnormalities and normal karyotypes are associated with typical lymphocyte morphology in B-cell chronic lymphocytic leukemia.
Kroft SH; Finn WG; Kay NE; Peterson LC
Am J Clin Pathol; 1997 Mar; 107(3):275-82. PubMed ID: 9052377
[TBL] [Abstract][Full Text] [Related]
22. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival.
Neilson JR; Auer R; White D; Bienz N; Waters JJ; Whittaker JA; Milligan DW; Fegan CD
Leukemia; 1997 Nov; 11(11):1929-32. PubMed ID: 9369428
[TBL] [Abstract][Full Text] [Related]
23. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
24. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of bone-marrow pattern and immunophenotypic score in B-chronic lymphocytic leukemia at diagnosis.
Jahic A; Iljazovic E; Arnautovic-Custovic A; Halilbasic A; Simendic V; Zabic A
Med Arh; 2011; 65(3):132-6. PubMed ID: 21776871
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic issues in chronic lymphocytic leukaemia (CLL).
Matutes E; Attygalle A; Wotherspoon A; Catovsky D
Best Pract Res Clin Haematol; 2010 Mar; 23(1):3-20. PubMed ID: 20620967
[TBL] [Abstract][Full Text] [Related]
27. Atypical lymphocytes in B-cell chronic lymphocytic leukemia and trisomy 12 studied by conventional staining combined with fluorescence in situ hybridization.
Hjalmar V; Kimby E; Matutes E; Sundström C; Wallvik J; Hast R
Leuk Lymphoma; 2000 May; 37(5-6):571-6. PubMed ID: 11042517
[TBL] [Abstract][Full Text] [Related]
28. Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia.
Podgornik H; Pretnar J; Skopec B; Andoljšek D; Černelč P
Hematology; 2014 Jan; 19(1):45-8. PubMed ID: 23432949
[TBL] [Abstract][Full Text] [Related]
29. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetics in CLL and related disorders.
Juliusson G; Gahrton G
Baillieres Clin Haematol; 1993 Dec; 6(4):821-48. PubMed ID: 8038492
[TBL] [Abstract][Full Text] [Related]
31. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
[TBL] [Abstract][Full Text] [Related]
33. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients.
Hancer VS; Diz-Kucukkaya R; Aktan M
Med Oncol; 2012 Jun; 29(2):1068-72. PubMed ID: 21264533
[TBL] [Abstract][Full Text] [Related]
35. The relationship between typical and atypical B-cell chronic lymphocytic leukemia. A comparative genomic hybridization-based study.
O'Connor SJ; Su'ut L; Morgan GJ; Jack AS
Am J Clin Pathol; 2000 Sep; 114(3):448-58. PubMed ID: 10989646
[TBL] [Abstract][Full Text] [Related]
36. Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia.
Sagatys EM; Zhang L
Cancer Control; 2012 Jan; 19(1):18-25. PubMed ID: 22143059
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
38. [Cytogenetic disorders in chronic B-cell lymphoid leukemia and their relations with clinicobiological features and prognosis of the disease].
Zakharova AI; Obukhova TN; Lorie IuIu; Nikitin EA; Samoĭlova RS; Zingerman BV; Domracheva EV
Ter Arkh; 2006; 78(7):57-62. PubMed ID: 16944752
[TBL] [Abstract][Full Text] [Related]
39. Morphologic identification of atypical chronic lymphocytic leukemia by digital microscopy.
Marionneaux S; Maslak P; Keohane EM
Int J Lab Hematol; 2014 Aug; 36(4):459-64. PubMed ID: 24400650
[TBL] [Abstract][Full Text] [Related]
40. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
